Related Experiment Video

Updated: Aug 7, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

12.8K

microRNA-29b-3p/sirtuin-1/peroxisome proliferator-activated receptor γ suppress osteogenic differentiation

Huanxin Xie1, Lei Cao2, Linlin Ye2

  • 1Department of Orthopedics, Beijing Rehabilitation Hospital, Capital Medical University, Xixiazhuang, Badachu Road, Shijingshan District, Beijing, 100144, People's Republic of China.

In Vitro Cellular & Developmental Biology. Animal
|March 7, 2023
PubMed

Insights

MicroRNA-29b-3p suppresses bone formation in osteoporosis by inhibiting the SIRT1/PPARγ pathway. Targeting this microRNA may offer a new treatment for postmenopausal osteoporosis.

Area of Science:

  • Molecular biology
  • Cell biology
  • Endocrinology

Background:

  • Osteoporosis is an age-related bone disorder characterized by impaired bone formation.
  • MicroRNA (miR)-29b-3p is implicated in osteoblast differentiation, but its precise role in osteoporosis remains unclear.
  • Understanding the molecular mechanisms of osteoporosis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of miR-29b-3p in osteoporosis.
  • To elucidate the molecular pathways involved in miR-29b-3p-mediated regulation of osteogenesis.
  • To explore potential therapeutic targets for postmenopausal osteoporosis.

Main Methods:

  • Established a murine model of estrogen deficiency-induced bone loss to mimic postmenopausal osteoporosis.
  • Quantified miR-29b-3p levels in bone tissue using RT-qPCR.
  • Examined the miR-29b-3p/sirtuin-1 (SIRT1)/peroxisome proliferator-activated receptor γ (PPARγ) axis in bone marrow mesenchymal stem cells (BMSCs) during osteogenic differentiation.
  • Assessed osteogenesis markers (ALP, OCN, RUNX2) at protein and molecular levels.
  • Utilized luciferase reporter assays to identify SIRT1 as a miR-29b-3p target.
  • Investigated the effects of SIRT1 overexpression and PPARγ activation (Rosiglitazone) on osteogenic differentiation.

Main Results:

  • Ovariectomized mice exhibited elevated miR-29b-3p levels.
  • miR-29b-3p mimics inhibited osteogenic differentiation and reduced osteogenesis markers in vitro and in vivo.
  • SIRT1 was confirmed as a direct target of miR-29b-3p.
  • SIRT1 overexpression partially rescued the inhibitory effects of miR-29b-3p on osteogenesis.
  • PPARγ signaling activation reversed miR-29b-3p inhibitor-induced suppression of BMSC osteogenic differentiation and PPARγ expression.
  • miR-29b-3p was found to suppress osteogenesis by inhibiting the SIRT1/PPARγ axis.

Conclusions:

  • miR-29b-3p plays a significant role in suppressing osteogenic differentiation in osteoporosis.
  • The miR-29b-3p/SIRT1/PPARγ axis is a key molecular pathway regulating bone formation in osteoporosis.
  • Targeting miR-29b-3p presents a potential therapeutic strategy for treating postmenopausal osteoporosis.
Keywords:
Osteoblast differentiationOsteoporosisPeroxisome proliferator–activated receptor γSirtuin-1miR-29b-3p

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.3K
Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

38.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K